Relay Therapeutics, Inc. (RLAY) stock
RLAYNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30
$16.51+0.04 (+0.24%)
Close on Nov 18, 2026Market cap $3.62BP/E –Yield –
Relay Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Relay Therapeutics's price to sales ratio was 416.4× on Nov 11, 2026, against 163.6× a year earlier. Over the last 2 years it ranged from 37.8× to 416.4×, with a median of 116.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 416.4× | +241.6 |
| 2025 | Dec 31, 2025 | 174.8× | +130.6 |
| 2024 | Jan 31, 2024 | 44.2× | −8.4 |
| 2023 | Dec 29, 2023 | 52.6× | – |
See a number that looks wrong?